Overview
- Multiple outlets reported Friday that President Trump approved a plan to fire FDA Commissioner Marty Makary, though no formal dismissal has occurred.
- A senior official cited complaints over Makary’s leadership, drug approval decisions, vaccine oversight, and his handling of the abortion pill mifepristone.
- The push followed a clash over flavored e‑cigarettes, with the FDA authorizing fruit flavors like mango and blueberry on Tuesday after Trump pressed for faster action.
- Senior White House staff planned to meet Friday evening with anti‑abortion activists who have criticized Makary and urged tighter limits on mifepristone.
- Any change at the top would come after steep staff turnover in FDA drug‑review offices over the past year, compounding HHS gaps that include no permanent CDC director and no surgeon general.